A functional magnetic resonance imaging study of tic suppression in tourette syndrome

Archives of General Psychiatry

Volumn 55, Issue 4, 1998, Pages 326-333

  Peterson, Bradley S ^a   Skudlarski, Pawel ^b   Andersen, Adam W ^b   Zhang, Heping ^b   Gatenby, J Chris ^b   Lacadie, Cheryl M ^b   Leckman, James F ^a   Gore, John C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COMORBIDITY; COMPULSION; DISEASE SEVERITY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMAGE ANALYSIS; MALE; MENTAL DISEASE; NEUROPSYCHIATRY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSION; SYMPTOMATOLOGY; THALAMUS; TIC;

ADOLESCENT; ADULT; BASAL GANGLIA; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TOURETTE SYNDROME; VOLITION;

EID: 0031945337     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.4.326     Document Type: Article

References (40)

1. Peterson BS, Leckman JF, Cohen DJ. Tourette's syndrome: a genetically predisposed and an environmentally specified developmental psychopathology. In: Cicchetti D, Cohen DJ, eds. Developmental Psychopathology. Vol 2. Risk, Disorder, and Adaptation. New York, NY: John Wiley & Sons Inc; 1995:213-242.
2. Leckman JF, Walker DE, Cohen DJ. Premonitory urges In Tourette's syndrome. Am J Psychiatry, 1993;150:98-102.
3. Cohen DJ, Young JG, Nathanson JA, Shaywitz BA. Clonidine in Tourette's syndrome. Lancet. 1979;2:551-553.
4. Cohen DJ, Shaywitz BA, Young JG, Carbonari CM, Nathanson JA, Lieberman D, Bowers M Jr, Maas JW. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry. 1979;18:320-341.
5. Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986;43:1180-1182.
6. Comings DE, Comings BG, Devor EJ, Cloninger CR. Detection of major gene for Gilles de la Tourette syndrome. Am J Hum Genet. 1984;36:586-600.
7. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566-573.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
9. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme Medical Publishers; 1988.
10. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and resliclng PET images. J Comput Assist Tomogr. 1992;16:620-633.
11. Hair JFJ, Anderson RE, Tatham RL, Black WC, Multivariate analysis of variance. In: Easter F, ed. Multivariate Data Analysis. Toronto, Ontario: Macmillan Publishing Co; 1992:153-181.
12. Efron B. Statistical data analysis in the computer age. Science. 1991;253:390-395.
13. Goldman-Rakic P. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Mountcastle V, Plum F, Gelger S, eds. Handbook of Physiology: The Nervous System, Bethesda, Md: American Physiological Society; 1987:373-416.
14. Parent A, Hazratl L. Functional anatomy of the basal ganglia, I: the cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev. 1995;20:91-127.
15. Grayblel AM, Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990;13:244-254.
16. Parthasarathy HB, Schall JD, Grayblel AM. Distributed but convergent ordering of corticostriatal projections: analysis of the frontal eye field and the supplementary eye field in the macaque monkey. J Neurosci. 1992;12:4468-4488.
17. Knight RT, Grabowecky MF, Scabini D. Role of human prefrontal cortex In attention control. In: Jasper HH, Riggio S, Goldman-Rakic PS, eds. Epilepsy and the Functional Anatomy of the Frontal Lobe. Vol 66. New York, NY: Raven Press Ltd; 1995:21-36.
18. Goldman-Rakic PS. Anatomical and functional circuits In prefrontal cortex of nonhuman primates. In: Jasper HH, Riggio S, Goldman-Rakic PS, eds. Epilepsy and the Functional Anatomy of the Frontal Lobe. Vol 66. New York, NY: Raven Press Ltd; 1995:51-65.
19. Petrides M. Specialized systems for the processing of mnemonic Information within the primate frontal cortex. Phllos Trans B Soc Lond B Blol Sci, 1996;351:1455-1462.
20. Goldman-Rakic PS, The prefrontal landscape: Implications of functional architecture for understanding human mentation and the central executive. Philos Trans R Soc Lond B Biol Sci. 1996;351:1445-1453.
21. Vogt BA, Finch DM, Oison OR. Functional heterogeneity In cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2:435-443.
22. Peterson B, Riddle MA, Cohen DJ, Katz LD, Smith JC, Hardln MT, Leckman JF. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology. 1993;43:941-949.
23. Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E, Harris EL, Reader MJ, Chase GA, Bryan RN, Denckla MB, Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology. 1993;43:950-956.
24. Hyde TM, Aaronson BA, Randolph C, Weinberger DR. Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins, Neurology. 1995;45:1176-1182.
25. Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, Coppola R, Weinberger DR. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science. 1996;273:1225-1227.
26. Roland PE. The cortical field is the unit of activation. In: Brain Activation. New York, NY: Wiley-LIss Inc; 1993:105-140.
27. Alexander G, Crutcher M, DeLong M. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal,' and limbic' functions. Prog Brain Res. 1990;85:119-146.
28. Leckman JF, Peterson BS, Anderson GM, Arnsten AFT, Pauls DL, Cohen DJ. Pathogenesls of Tourette's syndrome. J Child Psychol Psychiatry. 1997;38:119-142.
29. Chase TN, Geoffrey V, Gillespie M, Burrows GH. Structural and functional studies of Gilles de la Tourette syndrome. Rev Neurol. 1986;142:851-855.
30. Braun AR, Stoetter B, Randolph C, Msiao JK, Vladar K, Gernert J, Carson RE, Herscovitch P, Chase TN. The functional neuroanatomy of Tourette's syndrome: an FDG-PET study, I: regional changes In cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology. 1993;9:277-291.
31. Rauch SL, Jenike MA, AI pert NM, Baer L, Breiter HC, Savage CR, Fischman AJ. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 1994;51:62-70.
32. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD, Davis TL, Jiang A, Cohen MS, Stern CE, Belliveau JW, Baer L, O'Sulltvan RL, Savage CR, Jenike MA, Rosen BR. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:595-606.
33. Baxter LRJ, Phelps JM, Mazziotta JC, Guze BH, Schwarte JM. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and normal controls. Arch Gen Psychiatry. 1987;44:211-218.
34. Baxter L, Schwartz J, Mazziotta J, Phelps ME, Pah JJ, Buze BE, Fairbanks L. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder, Am J Psychiatry. 1988;145:1560-1563.
35. Swedo SE, Schapiro MB, Grady CL, Chesiow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46:518-523.
36. Baxter L Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, Phelps ME. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:681-689.
37. Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phelps ME. Systematic changes In cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:109-113.
38. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM. Local cerebral glucose metabolic rates In obsessive-compulsive disorder: patients treated with clomipramine. Arch Gen Psychiatry. 1990;47:840-848.
39. Swedo SE, Pletrlni P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI, Rapoport JL, Grady CL Cerebral glucose metabolism In childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry. 1992;49:690-694.
40. Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I, Regional [133]xenon cerebral blood flow and cerebral [99m]Tc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry. 1995;38:429-437.